biotech · Attention Deficit Hyperactivity Disorder · Vascular Ehlers-Danlos Syndrome · AYTU
AYTU BIOPHARMA
AYTU BIOPHARMA, INC
AYTU BIOPHARMA clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Denver, USA
- Founded
- 2015
- Employees
- 105
- Programs
- 3
- Drugs
- 5
- Patents
- 4
AYTU BIOPHARMA projects
3 ClinicalTrials.gov programs sponsored by AYTU BIOPHARMA.
AYTU BIOPHARMA has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Enzastaurin
AYTU BIOPHARMA, INC
Vascular Ehlers-Danlos Syndrome
1 trial -
ADZENYS XR-ODT
AYTU BIOPHARMA, INC
Attention Deficit Hyperactivity Disorder
1 trial -
Antioxidant
AYTU BIOPHARMA, INC
Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
1 trial
Frequently asked questions
How many clinical projects does AYTU BIOPHARMA have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.